484 related articles for article (PubMed ID: 34093144)
1. Dysfunction of Synaptic Vesicle Endocytosis in Parkinson's Disease.
Zou L; Tian Y; Zhang Z
Front Integr Neurosci; 2021; 15():619160. PubMed ID: 34093144
[TBL] [Abstract][Full Text] [Related]
2. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
Nguyen M; Krainc D
Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
[TBL] [Abstract][Full Text] [Related]
4.
Li W; Fu Y; Halliday GM; Sue CM
Front Cell Dev Biol; 2021; 9():612476. PubMed ID: 34295884
[TBL] [Abstract][Full Text] [Related]
5. A Proteome-Wide Effect of PHF8 Knockdown on Cortical Neurons Shows Downregulation of Parkinson's Disease-Associated Protein Alpha-Synuclein and Its Interactors.
Oey NE; Zhou L; Chan CHS; VanDongen AMJ; Tan EK
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831023
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of synaptic endocytic trafficking in Parkinson's disease.
Ng XY; Cao M
Neural Regen Res; 2024 Dec; 19(12):2649-2660. PubMed ID: 38595283
[TBL] [Abstract][Full Text] [Related]
7. Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Yahya V; Di Fonzo A; Monfrini E
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047309
[TBL] [Abstract][Full Text] [Related]
8. Co-occurrence of PRKN and SYNJ1 variants in Early-Onset Parkinson's disease.
Cotrin JC; Piergiorge RM; Gonçalves AP; Pereira JS; Gerber AL; de Campos Guimarães AP; de Vasconcelos ATR; Santos-Rebouças CB
Metab Brain Dis; 2024 Jun; ():. PubMed ID: 38836947
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
Sheehan P; Yue Z
Neurosci Lett; 2019 Apr; 697():59-65. PubMed ID: 29627340
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Leucine-Rich Repeat Kinase 2 Slows Synaptic Vesicle Recycling in Striatal Neurons.
Maas JW; Yang J; Edwards RH
Front Synaptic Neurosci; 2017; 9():5. PubMed ID: 28280464
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson's Disease.
Gcwensa NZ; Russell DL; Cowell RM; Volpicelli-Daley LA
Front Cell Neurosci; 2021; 15():626128. PubMed ID: 33737866
[TBL] [Abstract][Full Text] [Related]
12. Genetics of Parkinson's disease: a review of SNCA and LRRK2.
Konno T; Siuda J; Wszolek ZK
Wiad Lek; 2016; 69(3 Pt 1):328-32. PubMed ID: 27486710
[TBL] [Abstract][Full Text] [Related]
13. Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.
Oczkowska A; Kozubski W; Lianeri M; Dorszewska J
Curr Genomics; 2013 Dec; 14(8):502-17. PubMed ID: 24532983
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?
O'Hara DM; Pawar G; Kalia SK; Kalia LV
Front Neurosci; 2020; 14():577. PubMed ID: 32625052
[TBL] [Abstract][Full Text] [Related]
15. DJ-1 deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals.
Kyung JW; Kim JM; Lee W; Ha TY; Cha SH; Chung KH; Choi DJ; Jou I; Song WK; Joe EH; Kim SH; Park SM
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1629-1634. PubMed ID: 29386384
[TBL] [Abstract][Full Text] [Related]
16. Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies.
Rasool A; Manzoor R; Ullah K; Afzal R; Ul-Haq A; Imran H; Kaleem I; Akhtar T; Farrukh A; Hameed S; Bashir S
CNS Neurol Disord Drug Targets; 2024; 23(7):852-864. PubMed ID: 37303175
[TBL] [Abstract][Full Text] [Related]
17. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
Daher JP
Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
[TBL] [Abstract][Full Text] [Related]
18. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
20. The genetic landscape of Parkinson's disease.
Lunati A; Lesage S; Brice A
Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
